Remove Cardiology Remove Genetic Disease Remove RNA
article thumbnail

Tryngolza (Olezarsen) Becomes First FDA-Approved Drug for Familial Chylomicronemia Syndrome

XTalks

For the first time in the US, adults living with familial chylomicronemia syndrome (FCS) have an FDA-approved treatment option.